bpc. 157 Bpc-157 | C62H98N16O22 | CID 9941957 BPC-157 — Evolved Science

All use is strictly in-vitro laboratory research

Moreover, the use of clinical biomarkers to determine the risk of progression to EAC in patients with BE has been studied and has shown potential to improve risk stratification of patients with BE

Monique Sensenbrenner at a French lab and Gertrude Lindler at a German lab both demonstrated this effect in cell cultures, providing cross-laboratory validation of the nerve growth-promoting properties

So a 5 mg vial contains 5,000 mcg, and a 250 mcg dose is 0.25 mg

It is essentially a synthetic version of thymosin beta-4, a protein located in the thymus gland

TB-500 research is the gold standard in equine and athletic musculoskeletal models